Delivered March 21, 2018 This content is archived.
Good afternoon! Welcome and thank you for coming.
I am pleased to join all of you here for today’s forum. This is a great opportunity to get updated on the latest progress related to the CTSA and share ideas as we move forward.
Recognizing this research as a clear national priority, the National Institutes of Health began investing in the Clinical and Translational Science Awards program in 2006. And now, thanks to our 2015 award, UB is proud to lead one of 63 CTSA Hubs in the nation aimed at:
As you know, the investment in health care from both the private and public sector is immense. And experts in both sectors widely agree that the health care system in the U-S needs to be improved in many ways in order:
Here at UB, we are also committed to growing our investment in clinical research—from the construction of this new building for the Jacobs School of Medicine and Biomedical Sciences, to the planned hiring of 100 new faculty researchers and clinicians. The CTSA allows UB to fully leverage—and build upon—the substantial research strength and clinical collaborations we have developed over the years with our partners on the Buffalo Niagara Medical Campus.
Indeed, the vision of our Clinical and Translational Science Institute and the greater Buffalo Translational Consortium is to develop, test, and share innovative approaches to improve health and reduce health disparities in Buffalo. This exciting work in clinical and translational research holds great promise for even more effective and efficient ways to improve the health of the citizens here in Western New York and beyond.
The investments we are making in:
are essential to generate new discoveries, and to move promising findings in basic science and clinical research from the bench to the bedside.
The research being done as a result of the CTSA is offering great potential to create new preventive measures and discover new treatments. The strong leadership, creative partnerships, and commitment of each member of the Buffalo Translational Consortium is vital to this effort. All of our partners are contributing to our successful, yet continuously-evolving, plan for the CTSA. This collaboration is making remarkable progress to further advance clinical and translational science and improve human health.
We look forward to seeing this potential fully realized in the coming years.
Thank you again for joining us today, and I wish you all the best for a most productive forum.
